Alx Oncology Holdings Inc SEC filings ALXO
Alx Oncology Holdings Inc has 421 filings in SEC EDGAR's recent list, going back to May 5, 2020. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 24, 2025 | — |
| CORRESP | Letter to the SEC | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| SC TO-I/A | Filing | Dec 31, 2024 | — |
| SC TO-I | Filing | Dec 2, 2024 | — |
| EFFECT | Filing | Sep 8, 2023 | — |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| EFFECT | Filing | May 31, 2022 | — |
| EFFECT | Filing | May 25, 2022 | — |
| CORRESP | Letter to the SEC | May 24, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2022 | — |
| EFFECT | Filing | Dec 9, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2020 | — |
| DRS | Filing | Nov 24, 2020 | — |
| EFFECT | Filing | Jul 16, 2020 | — |
| CERT | Filing | Jul 16, 2020 | — |
| CORRESP | Letter to the SEC | Jul 14, 2020 | — |
| CORRESP | Letter to the SEC | Jul 14, 2020 | — |
| 8-A12B | Filing | Jul 13, 2020 | — |
| CORRESP | Letter to the SEC | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jun 26, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2020 | — |
| DRSLTR | Filing | Jun 12, 2020 | — |
| DRS/A | Filing | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2020 | — |
| DRSLTR | Filing | May 5, 2020 | — |
| DRS | Filing | May 5, 2020 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALXO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1810182
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.